J.P. Morgan on Wednesday launched its coverage of ANI Pharmaceuticals (NASDAQ:ANIP) with an Overweight recommendation and a ...
US President Donald Trump on Saturday (local time) announced “decisive and powerful” military action against Yemen’s Houthi ...
Jefferies initiated coverage of ANI Pharmaceuticals (ANIP) with a Buy rating and $80 price target The firm expects continued momentum for the ...
Does storing copyrighted material amount to infringement? Read what the amicus curiae in the ANI vs OpenAI case said about ...
This year's best picture winner at the Oscars starts out as a kind of romantic comedy, but things get real pretty quick.
The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...
The jewelry company owes Love $6 million in royalties, and more than $200,000 in unpaid consulting fees, the suit says.
JPMorgan initiated coverage of ANI Pharmaceuticals (ANIP) with an Overweight rating and $85 price target ANI is a specialty pharmaceuticals ...
Addressing the legal implications of public accessibility, Advocate Ramanujan argued that the mere availability of content in ...
The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results